These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 34029516)

  • 1. Biologic Therapy for Psoriasis During the COVID-19 Pandemic: A Case Series of Patients Treated in Hospital Universitario Son Espases.
    Gracia-Darder I; Garcías-Ladaria J; Ramos Rodríguez D; Escalas Taberner J
    Actas Dermosifiliogr; 2022 Jan; 113(1):110-112. PubMed ID: 34029516
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic Therapy for Psoriasis During the COVID-19 Pandemic: A Case Series of Patients Treated in Hospital Universitario Son Espases.
    Gracia-Darder I; Garcías-Ladaria J; Ramos Rodríguez D; Escalas Taberner J
    Actas Dermosifiliogr; 2021 Oct; ():. PubMed ID: 34728837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nuclear medicine in the diagnosis of peritoneal leaks in patients in dialysis: Experience of Hospital Universitario Son Espases.
    Amaya J; Rubí S; Munar M; García JL; Medina C; Luna B; Sampol C; Peña C
    Nefrologia (Engl Ed); 2023; 43(1):155-157. PubMed ID: 37012172
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.
    Polat Ekinci A; Pehlivan G; Gökalp MO
    Dermatol Ther; 2021 Jan; 34(1):e14700. PubMed ID: 33369063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Brownstone ND; Thibodeaux QG; Reddy VD; Myers BA; Chan SY; Bhutani T; Liao W
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):881-885. PubMed ID: 32468230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.
    Kado S; Kamiya K; Kishimoto M; Maekawa T; Kuwahara A; Sugai J; Komine M; Ohtsuki M
    J Dermatol; 2021 Dec; 48(12):1907-1912. PubMed ID: 34549456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis, biologic therapy, and the pandemic of the 21st century.
    Nogueira M; Vender R; Torres T
    Drugs Context; 2020; 9():. PubMed ID: 32477419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics for Psoriasis During the COVID-19 Pandemic.
    Zeng H; Wang S; Chen L; Shen Z
    Front Med (Lausanne); 2021; 8():759568. PubMed ID: 34938746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.
    Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Piaserico S; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Rossi MT; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavo' SP; Rech G; Prignano F; Offidani A; Lombardo M; Zalaudek I; Bianchi L; Peris K; ; Balestri R ; Bernardini N ; Belloni Fortini A ; Burlando M ; Caldarola G ; Campione E ; Cattaneo A ; Dapavo P ; Dastoli S ; De Simone C ; Di Nuzzo S ; Diotallevi F ; Fierro MT ; Franchi C ; Esposito M ; Foti C ; Gambini DM ; Gambardella A ; Girolomoni G ; Giunta A ; Guarneri C ; Gualdi G ; Hansel K ; Megna M ; Mugheddu C ; Musumeci ML ; Patrizi A ; Pellacani G ; Richetta AG ; Rosi E ; Sacchelli L ; Tiberio R ; Tilotta G ; Trovato E ; Venturini M ; Vezzoni R
    Expert Opin Biol Ther; 2021 Feb; 21(2):271-277. PubMed ID: 33216643
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic treatment of recalcitrant pediatric psoriasis: a case series from a tertiary medical center.
    Ollech A; Zvulunov A; Pavlovsky L; Hodak E; Ben-Amitai D
    J Dermatolog Treat; 2019 Mar; 30(2):152-155. PubMed ID: 29757046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient's perception: Study on 600 patients on biologic therapy.
    Bernardini N; Skroza N; Spagnoli A; Marchesiello A; Balduzzi V; Tolino E; Mambrin A; Michelini S; Maddalena P; Volpe S; Proietti I; Vestri A; Potenza C
    J Infect Public Health; 2021 Jul; 14(7):878-882. PubMed ID: 34118738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset or worsening of psoriasis following biologic therapy: A case series.
    Bruzzese V; De Francesco V; Hassan C; Lorenzetti R; Scolieri P; Marrese C; Zullo A
    Int J Immunopathol Pharmacol; 2017 Mar; 30(1):70-72. PubMed ID: 28134599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
    Rosi E; Pimpinelli N; Prignano F
    J Dermatolog Treat; 2022 Feb; 33(1):599. PubMed ID: 32432955
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis.
    Esse S; Mason KJ; Green AC; Warren RB
    JAMA Dermatol; 2020 Jul; 156(7):787-794. PubMed ID: 32432649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Brain Stimulation of the Nucleus Accumbens, Ventral Striatum, or Internal Capsule Targets for Medication-Resistant Obsessive-Compulsive Disorder: A Multicenter Study.
    Torres Díaz CV; Treu S; Strange B; Lara M; Navas M; Ezquiaga E; Zazo ES; Vicente JS; Muñiz I; Fernandez FS
    World Neurosurg; 2021 Nov; 155():e168-e176. PubMed ID: 34403796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certolizumab pegol in the treatment of psoriasis: Real-life data.
    Turkmen M; Dogan S
    Dermatol Ther; 2021 May; 34(3):e14929. PubMed ID: 33665940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
    Fonia A; Jackson K; Lereun C; Grant DM; Barker JN; Smith CH
    Br J Dermatol; 2010 Oct; 163(4):807-16. PubMed ID: 20662837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perception of the threat, mental health burden, and healthcare-seeking behavior change among psoriasis patients during the COVID-19 pandemic.
    Chiu HY; Chang Liao NF; Lin Y; Huang YH
    PLoS One; 2021; 16(12):e0259852. PubMed ID: 34882690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
    Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
    J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.